Back to top

earnings-consensus: Archive

Zacks Equity Research

Does Copa Holdings (CPA) Have the Potential to Rally 49.43% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 49.4% in Copa Holdings (CPA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

CPANegative Net Change

Zacks Equity Research

BioHarvest Sciences Inc. (BHST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

BioHarvest Sciences Inc. (BHST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BHSTPositive Net Change OCSNegative Net Change

Zacks Equity Research

Birkenstock (BIRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Birkenstock (BIRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BIRKPositive Net Change

Zacks Equity Research

Earnings Preview: Bitdeer Technologies Group (BTDR) Q1 Earnings Expected to Decline

BITDEER TEC GRP (BTDR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BTDRNegative Net Change DUOTPositive Net Change

Zacks Equity Research

Super League Enterprise (SLE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Super League Enterprise (SLE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SLENegative Net Change

Zacks Equity Research

Analysts Estimate Walmart (WMT) to Report a Decline in Earnings: What to Look Out for

Walmart (WMT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WMTNegative Net Change

Zacks Equity Research

Applied Materials (AMAT) Earnings Expected to Grow: Should You Buy?

Applied Materials (AMAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMATNegative Net Change

Zacks Equity Research

Globant (GLOB) Earnings Expected to Grow: Should You Buy?

Globant (GLOB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GLOBNegative Net Change

Zacks Equity Research

Knightscope, Inc. (KSCP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Knightscope (KSCP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KSCPPositive Net Change BITFNegative Net Change

Zacks Equity Research

Analysts Estimate Deere (DE) to Report a Decline in Earnings: What to Look Out for

Deere (DE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DEPositive Net Change

Zacks Equity Research

Flexible Solutions International Inc. (FSI) Earnings Expected to Grow: Should You Buy?

Flexible Solutions International (FSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FSIPositive Net Change HWKNNegative Net Change

Zacks Equity Research

Cava Group (CAVA) Earnings Expected to Grow: Should You Buy?

Cava (CAVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CAVAPositive Net Change JACKNegative Net Change

Zacks Equity Research

Gambling.com Group Limited (GAMB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Gambling.com (GAMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GAMBNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe Immunome (IMNM) Could Rally 249.93%: Here's is How to Trade

The consensus price target hints at a 249.9% upside potential for Immunome (IMNM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

IMNMPositive Net Change

Zacks Equity Research

Wall Street Analysts Believe Barrick Gold (GOLD) Could Rally 25.72%: Here's is How to Trade

The consensus price target hints at a 25.7% upside potential for Barrick Gold (GOLD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet

The mean of analysts' price targets for Rigel (RIGL) points to an 82.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

RIGLNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe Unity Software (U) Could Rally 27.69%: Here's is How to Trade

The mean of analysts' price targets for Unity Software (U) points to a 27.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

UPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet

The consensus price target hints at a 41.2% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SIBNNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 25.24% Upside in Clearway Energy (CWEN): Here's What You Should Know

The mean of analysts' price targets for Clearway Energy (CWEN) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CWENPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 32.29% Upside in Adeia (ADEA): Can the Stock Really Move This High?

The consensus price target hints at a 32.3% upside potential for Adeia (ADEA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ADEANegative Net Change

Zacks Equity Research

Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?

The consensus price target hints at a 26.5% upside potential for Adaptive Biotechnologies (ADPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ADPTNegative Net Change

Zacks Equity Research

Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect?

The consensus price target hints at a 51.2% upside potential for Novo Nordisk (NVO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

NVONegative Net Change

Zacks Equity Research

Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Pfizer (PFE) points to a 25.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

PFENegative Net Change

Zacks Equity Research

Does BioCryst (BCRX) Have the Potential to Rally 61.21% as Wall Street Analysts Expect?

The mean of analysts' price targets for BioCryst (BCRX) points to a 61.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

BCRXNegative Net Change

Zacks Equity Research

Navigator Holdings (NVGS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Navigator Holdings (NVGS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NVGSPositive Net Change